NCT05745311View on ClinicalTrials.gov

Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke

PHASE2UnknownINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

May 1, 2024

Study Completion Date

July 30, 2024

Conditions
Acute Ischemic Stroke
Interventions
DRUG

The KPCXM18 injection

Intravenous infusion

DRUG

Placebo

Intravenous infusion

Sponsors
All Listed Sponsors
lead

Kunming Pharmaceuticals, Inc.

INDUSTRY